Week of January 3, 2024 | Vol. 13, Issue 1

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company



Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable CDMO

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Global CDMO Agno Pharma Completes Acquisition of Particle Sciences Inc.

Business Wire - Dec 18, 2023

Rentschler’s New CEO On 2024 Expectations For CDMOs

In Vivo - Dec 18, 2023

Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration

Business Wire - Dec 18, 2023

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

LTS - Dec 19, 2023

Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity

PR Newswire - Dec 19, 2023

World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

PR Newswire - Dec 19, 2023

ZyVersa taps George Clinical to run kidney disease trial

Fierce Biotech - Dec 20, 2023

Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries

PR Newswire - Dec 20, 2023

Clemson University unit teams up with CRO Precia to reach out to underserved rural communities

Fierce Biotech - Dec 20, 2023

TANNER NEWS

Tanner | A Rare Affair | JPM Conference

We're excited to serve as a sponsor for A Rare Affair 2024, a wonderful evening of networking, wine and food hosted by Ultragenyx at the JP Morgan Healthcare Conference. We hope you will join us on January 7th. Learn more.